Citadel Advisors’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$269K Sell
41,301
-50,812
-55% -$316K ﹤0.01% 10713
2025
Q4
$527K Buy
92,113
+11,192
+14% +$69K ﹤0.01% 8904
2025
Q3
$552K Buy
80,921
+35,695
+79% +$270K ﹤0.01% 8891
2025
Q2
$406K Sell
45,226
-30,963
-41% -$184K ﹤0.01% 9110
2025
Q1
$410K Buy
76,189
+23,482
+45% +$160K ﹤0.01% 8917
2024
Q4
$393K Sell
52,707
-39,032
-43% -$321K ﹤0.01% 9095
2024
Q3
$829K Buy
91,739
+19,448
+27% +$201K ﹤0.01% 7237
2024
Q2
$768K Buy
72,291
+25,653
+55% +$273K ﹤0.01% 7142
2024
Q1
$411K Buy
46,638
+9,040
+24% +$73.6K ﹤0.01% 8815
2023
Q4
$256K Buy
37,598
+21,567
+135% +$177K ﹤0.01% 9475
2023
Q3
$156K Sell
16,031
-609
-4% -$4.88K ﹤0.01% 10295
2023
Q2
$80.5K Sell
16,640
-12,658
-43% -$55K ﹤0.01% 11244
2023
Q1
$118K Buy
29,298
+9,235
+46% +$37.1K ﹤0.01% 11030
2022
Q4
$77.4K Buy
+20,063
New +$92.5K ﹤0.01% 11565
2014
Q2
Sell
-14,372
Closed -$61K 8322
2014
Q1
$61K Buy
+14,372
New +$55.2K ﹤0.01% 6611

Other funds holding ULBI

Citadel Advisors's ULBI Position: Q1 2026 in Review

Citadel Advisors reduced its Ultralife (ULBI) stake by 55% in Q1 2026, selling an estimated $316K and leaving 41,301 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #10713.

Citadel Advisors first reported a position in ULBI in Q1 2014 and has held it in 15 quarters since. The position peaked at $829K in Q3 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Citadel Advisors held 41,301 shares of Ultralife worth $269K as of Q1 2026.
  • Citadel Advisors sold 50,812 Ultralife shares in Q1 2026, an estimated $316K.
  • Ultralife made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10713 holding.
  • Citadel Advisors first reported a position in Ultralife in Q1 2014 and has held it in 15 quarters since.
  • Citadel Advisors's Ultralife position peaked at $829K in Q3 2024.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.